![Christopher Frankenfield](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christopher Frankenfield
Financieel Directeur/CFO bij
XILIO THERAPEUTICS, INC.
Vermogen: 14 966 $ op 31-05-2026
Profiel
Mr. Christopher Frankenfield is a Chief Operating & Financial Officer at Xilio Therapeutics, Inc. Mr. Frankenfield was previously employed as a Vice President-Corporate & Legal Affairs by Blueprint Medicines Corp.
and a Senior Associate by Wilmer Cutler Pickering Hale & Dorr LLP.
He received his undergraduate degree from The College of William & Mary and a graduate degree from the University of Virginia School of Law.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 02-01-2026 | 1.769 ( 0,03% ) | 14 966 $ | 31-05-2026 |
Actieve functies van Christopher Frankenfield
| Bedrijven | Functie | Begin |
|---|---|---|
| XILIO THERAPEUTICS, INC. | Financieel Directeur/CFO | 08-08-2024 |
Eerdere bekende functies van Christopher Frankenfield
| Bedrijven | Functie | Einde |
|---|---|---|
| BLUEPRINT MEDICINES CORPORATION | Algemeen Adviseur | 01-03-2021 |
Wilmer Cutler Pickering Hale & Dorr LLP
 Wilmer Cutler Pickering Hale & Dorr LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Corporate Officer/Principal | - |
Opleiding van Christopher Frankenfield
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
12
Eerstegraads connecties
5
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Wilmer Cutler Pickering Hale & Dorr LLP
Wilmer Cutler Pickering Hale & Dorr LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
The College of William & Mary
 The College of William & Mary Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Blueprint Medicines Corp.
 Blueprint Medicines Corp. BiotechnologyHealth Technology Develops cancer therapies that harness the growing understanding of the molecular blueprint of cancer | Health Technology |
University of Virginia School of Law
 University of Virginia School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Xilio Therapeutics, Inc.
 Xilio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which develops tumor-selective immuno-oncology therapies | Health Technology |
Kies MarketScreener 
